HL
Therapeutic Areas
Tiziana Life Sciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Foralumab (intranasal) | Non-Active Secondary Progressive Multiple Sclerosis | Phase 2 |
| TZLS-501 | Lung Diseases | Preclinical |
| Milciclib | NSCLC (pan-KRAS+) | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Foralumab (intranasal) | Non-Active Secondary Progressive Multiple Sclerosis | Phase 2 |
| TZLS-501 | Lung Diseases | Preclinical |
| Milciclib | NSCLC (pan-KRAS+) | Preclinical |